• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症和精神病的处方用药:随着时间推移,联合用药情况日益增多。

Prescribing in schizophrenia and psychosis: Increasing polypharmacy over time.

作者信息

Heald Adrian, Livingston Mark, Yung Alison, De Hert M A

机构信息

School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.

Department of Medicine, Leighton Hospital, Crewe, UK.

出版信息

Hum Psychopharmacol. 2017 Mar;32(2). doi: 10.1002/hup.2579.

DOI:10.1002/hup.2579
PMID:28370308
Abstract

INTRODUCTION

Diabetes, obesity, and metabolic syndrome are highly prevalent in patients with severe mental illness. Psychotropic polypharmacy is becoming increasingly prevalent within the UK. We determined the change in the number of psychotropic medications prescribed over time and trends in weight and fasting blood glucose.

METHODS

One hundred ninety-five individuals with schizophrenia and psychosis on the Severe Mental Illness Register in Cheshire, UK, were followed up between 2004 and 2012. Individuals were identified through a semianonymised search of general practitioner registers.

RESULTS

The total number of different medications prescribed increased from 140 in 2004 to 226 in 2012 with the mean number of medication groups per patient increasing from 0.71 to 1.15 (p < .001). The number of individuals on no medication reduced from 58.0% to 33.3%, OR 0.36 95% CI [0.24, 0.54], and those prescribed one medication increased from 20.5% to 31.8%, OR 1.93 95% CI [1.22-3.06]. Baseline body mass index was 28.9, increasing to 30.8 at 8-year follow-up, F(6.5), p = .003, with a significant corresponding increase in fasting blood glucose.

CONCLUSION

In conclusion, we determined an increase in psychotropic polypharmacy over the follow-up period. Body mass index or fasting blood glucose increased over time. Clozapine and depot antipsychotic prescriptions were often not recorded in the general practitioner records.

摘要

引言

糖尿病、肥胖症和代谢综合征在重症精神疾病患者中极为普遍。在英国,联合使用多种精神药物的情况日益常见。我们确定了随时间推移开具的精神药物数量的变化以及体重和空腹血糖的趋势。

方法

对英国柴郡严重精神疾病登记册上的195名精神分裂症和精神病患者在2004年至2012年期间进行了随访。通过对全科医生登记册进行半匿名搜索来确定这些个体。

结果

所开具的不同药物总数从2004年的140种增加到2012年的226种,每位患者的药物组平均数量从0.71增加到1.15(p <.001)。未用药的个体数量从58.0%降至33.3%,比值比为0.36,95%置信区间为[0.24, 0.54],而开具一种药物的个体数量从20.5%增加到31.8%,比值比为1.93,95%置信区间为[1.22 - 3.06]。基线体重指数为28.9,在8年随访时增至30.8,F(6.5),p =.003,空腹血糖也相应显著增加。

结论

总之,我们发现在随访期间联合使用多种精神药物的情况有所增加。体重指数或空腹血糖随时间增加。氯氮平和长效抗精神病药物的处方在全科医生记录中常常未被记录。

相似文献

1
Prescribing in schizophrenia and psychosis: Increasing polypharmacy over time.精神分裂症和精神病的处方用药:随着时间推移,联合用药情况日益增多。
Hum Psychopharmacol. 2017 Mar;32(2). doi: 10.1002/hup.2579.
2
Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.英国一家高度戒备医院中,针对患有精神分裂症或人格障碍的严重暴力倾向男性的精神药物处方情况。
CNS Spectr. 2016 Feb;21(1):60-9. doi: 10.1017/S1092852915000784. Epub 2016 Jan 4.
3
Maintenance phase treatment of psychotic disorders in outpatients from Serbia - focus on long-term benzodiazepine use.塞尔维亚门诊精神病患者的维持期治疗 - 关注长期使用苯二氮䓬类药物。
Int J Psychiatry Clin Pract. 2020 Sep;24(3):315-321. doi: 10.1080/13651501.2020.1767788. Epub 2020 May 27.
4
National trends in psychotropic medication polypharmacy in office-based psychiatry.基于办公室的精神病学中精神药物联合用药的全国趋势。
Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175.
5
Prescribing Patterns of Psychotropic Drugs and Risk of Violent Behavior: A Prospective, Multicenter Study in Italy.精神药物处方模式与暴力行为风险:意大利一项前瞻性、多中心研究。
Int J Neuropsychopharmacol. 2020 May 27;23(5):300-310. doi: 10.1093/ijnp/pyaa005.
6
Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis.抗精神病药物在治疗抵抗性精神病的三级护理计划入院时和出院时的处方模式。
PLoS One. 2018 Aug 10;13(8):e0199758. doi: 10.1371/journal.pone.0199758. eCollection 2018.
7
Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries: Fourth survey of Research on Asian Prescription Patterns on antipsychotics.亚洲国家精神分裂症患者的药物滥用和精神药物负荷:亚洲抗精神病药物处方模式研究第四次调查。
Psychiatry Clin Neurosci. 2018 Aug;72(8):572-579. doi: 10.1111/pcn.12676. Epub 2018 Jun 19.
8
Changes in metabolic parameters in patients with severe mental illness over a 10-year period: A retrospective cohort study.重度精神疾病患者10年间代谢参数的变化:一项回顾性队列研究。
Aust N Z J Psychiatry. 2017 Jan;51(1):75-82. doi: 10.1177/0004867415625817. Epub 2016 Sep 29.
9
Psychotropic medication treatment patterns in community-dwelling schizophrenia in China: comparisons between rural and urban areas.中国社区精神分裂症患者的精神药物治疗模式:城乡比较。
BMC Psychiatry. 2019 Aug 5;19(1):242. doi: 10.1186/s12888-019-2217-1.
10
A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.一项关于西班牙塔拉戈纳省精神分裂症患者抗精神病药物处方模式的非干预性自然主义研究。
PLoS One. 2015 Oct 1;10(10):e0139403. doi: 10.1371/journal.pone.0139403. eCollection 2015.

引用本文的文献

1
Impact of Early Antipsychotic Prescription Choice on Weight Gain in the First 5 Years of Psychotic Illness: a Retrospective Cohort Study.早期抗精神病药物处方选择对精神病性疾病前5年体重增加的影响:一项回顾性队列研究
Neurol Ther. 2025 Jun 19. doi: 10.1007/s40120-025-00780-4.
2
Global Neuropsychopharmacological Prescription Trends in Adults with Schizophrenia, Clinical Correlates and Implications for Practice: A Scoping Review.成人精神分裂症患者的全球神经精神药理学处方趋势、临床关联及实践意义:一项范围综述
Brain Sci. 2023 Dec 20;14(1):6. doi: 10.3390/brainsci14010006.
3
Weight change following diagnosis with psychosis: a retrospective cohort study in Greater Manchester, UK.
精神病诊断后的体重变化:英国大曼彻斯特地区的一项回顾性队列研究
Ann Gen Psychiatry. 2024 Jan 3;23(1):1. doi: 10.1186/s12991-023-00485-8.
4
Prevalence and risk factors for misuse of prescription psychotropic drug in patients with severe mental illness: A systematic review.严重精神障碍患者处方精神药物滥用的流行状况和危险因素:系统评价。
Actas Esp Psiquiatr. 2023 Sep;51(5):229-240. Epub 2023 Sep 1.
5
Relationships Between Adherence to Guideline Recommendations for Pharmacological Therapy Among Clinicians and Psychotic Symptoms in Patients With Schizophrenia.临床医生对精神分裂症患者药物治疗指南建议的遵从度与患者精神病症状之间的关系。
Int J Neuropsychopharmacol. 2023 Aug 29;26(8):557-565. doi: 10.1093/ijnp/pyad037.
6
First episode psychosis and weight gain a longitudinal perspective in Cheshire UK: a comparison between individuals with nonaffective versus affective psychosis.首发精神病与体重增加:英国柴郡的纵向研究视角——非情感性精神病与情感性精神病患者的比较
Cardiovasc Endocrinol Metab. 2023 Jun 22;12(3):e0286. doi: 10.1097/XCE.0000000000000286. eCollection 2023 Sep.
7
Psychiatric and non-psychiatric polypharmacy among older adults with schizophrenia: Trends from a population-based study between 2000 and 2016.老年精神分裂症患者的精神科与非精神科联合用药情况:基于2000年至2016年一项人群研究的趋势
Front Pharmacol. 2023 Feb 7;14:1080073. doi: 10.3389/fphar.2023.1080073. eCollection 2023.
8
Links between the amount of antipsychotic medication prescribed per population at general practice level, local demographic factors and medication selection.基层医疗水平上为每一个人群开的抗精神病药物的剂量之间的联系,当地人口因素和药物选择。
BMC Psychiatry. 2020 Nov 7;20(1):528. doi: 10.1186/s12888-020-02915-3.
9
Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders.精神分裂症谱系障碍和双相情感障碍治疗第一年抗精神病药物剂量变化的预测因素
Front Psychiatry. 2019 Sep 10;10:649. doi: 10.3389/fpsyt.2019.00649. eCollection 2019.
10
Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study.精神分裂症患者的精神药理学治疗:30908 名住院患者的长期随访数据:来自 AMSP 研究。
Int J Neuropsychopharmacol. 2019 Sep 1;22(9):560-573. doi: 10.1093/ijnp/pyz037.